215 related articles for article (PubMed ID: 16843129)
1. Imatinib-induced eccrine squamous syringometaplasia.
Van de Voorde K; De Raeve H; Van Regenmortel N; Lambert J
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S58-9. PubMed ID: 16843129
[No Abstract] [Full Text] [Related]
2. Chemotherapy-induced eccrine squamous syringometaplasia in an infant.
Bittar PG; Casady M; Selim MA; Prose NS
Pediatr Dermatol; 2018 Jan; 35(1):e84-e85. PubMed ID: 29231256
[TBL] [Abstract][Full Text] [Related]
3. [Eccrine squamous syringometaplasia from chemotherapy extravasation].
Bordel MT; Miranda A
Actas Dermosifiliogr; 2005 Sep; 96(7):462-4. PubMed ID: 16476276
[TBL] [Abstract][Full Text] [Related]
4. Eccrine squamous syringometaplasia secondary to cutaneous extravasation of docetaxel: report of three cases.
Gallo E; Llamas-Velasco M; Navarro R; Fraga J; García-Diez A
J Cutan Pathol; 2013 Mar; 40(3):326-9. PubMed ID: 23170995
[TBL] [Abstract][Full Text] [Related]
5. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
Story SG; Beschloss JK; Dolan CK; Thomas BC
J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
[No Abstract] [Full Text] [Related]
6. Follicular acneiform eruption induced by imatinib.
Martín JM; Jordá E; Monteagudo C; Alonso V; García L; Villalón G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1368-70. PubMed ID: 17062082
[No Abstract] [Full Text] [Related]
7. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
Scheinfeld N
J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
[TBL] [Abstract][Full Text] [Related]
8. Eccrine squamous syringometaplasia associated with dabrafenib therapy.
Liuti F; Martín PA; Montenegro Damaso T; Abreu DR; Santana JH
J Am Acad Dermatol; 2013 Nov; 69(5):e273-e274. PubMed ID: 24124864
[No Abstract] [Full Text] [Related]
9. Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism.
Vano-Galvan S; Fernandez-Guarino M; Henriquez-Santana A; De Las Heras E; Calbacho M; Jaen P
Eur J Dermatol; 2007; 17(6):538-9. PubMed ID: 17951138
[No Abstract] [Full Text] [Related]
10. Tamoxifen-induced eccrine squamous syringometaplasia.
Teoh DC; Aw DC; Jaffar H; Ling W; Yong WP; Lee YS; Choo SN; Tan KB
J Cutan Pathol; 2012 May; 39(5):554-7. PubMed ID: 22390276
[TBL] [Abstract][Full Text] [Related]
11. Dermatitis after suspected imatinib-levothyroxine interaction in a patient with gastrointestinal stromal tumor.
Cholongitas E; Pipili C; Katsogridakis K; Relos K; Dasenaki M
Cancer Chemother Pharmacol; 2008 May; 61(6):1083-4. PubMed ID: 17680243
[No Abstract] [Full Text] [Related]
12. Eccrine squamous syringometaplasia and cytomegalovirus.
Daudén E; Porras JI; Buezo GF; García-Díez A
Am J Dermatopathol; 2000 Dec; 22(6):559-61. PubMed ID: 11190451
[No Abstract] [Full Text] [Related]
13. [Asymptomatic inguinal micropapules in a patient treated with chemotherapy].
Del Boz J; Sanz A; Samaniego E
Actas Dermosifiliogr; 2008 Oct; 99(8):655-6. PubMed ID: 19080899
[No Abstract] [Full Text] [Related]
14. Vemurafenib-induced eccrine squamous syringometaplasia.
Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological features.
Martorell-Calatayud A; Sanmartín O; Botella-Estrada R; Balmer NN; Serra-Guillén C; Gomez-Moyano E; Traves-Zapata V; Requena C; Nagore E; Llombart-Cussac B; Guillen-Barona C
J Am Acad Dermatol; 2011 Jun; 64(6):1092-103. PubMed ID: 21489654
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced eccrine squamous syringometaplasia. A distinctive eruption in patients receiving hematopoietic progenitor cells.
Valks R; Fraga J; Porras-Luque J; Figuera A; Garcia-Diéz A; Fernändez-Herrera J
Arch Dermatol; 1997 Jul; 133(7):873-8. PubMed ID: 9236526
[TBL] [Abstract][Full Text] [Related]
17. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
[No Abstract] [Full Text] [Related]
18. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
Dalmau J; Peramiquel L; Puig L; Fernández-Figueras MT; Roé E; Alomar A
Br J Dermatol; 2006 Jun; 154(6):1213-6. PubMed ID: 16704665
[No Abstract] [Full Text] [Related]
19. Lichenoid drug eruption related to imatinib: report of a new case and review of the literature.
Sendagorta E; Herranz P; Feito M; Ramírez P; Feltes R; Floristán U; Mariño-Enriquez A; Casado M
Clin Exp Dermatol; 2009 Oct; 34(7):e315-6. PubMed ID: 19456782
[No Abstract] [Full Text] [Related]
20. Eccrine squamous syringometaplasia in sites of radiation recall secondary to vemurafenib therapy for BRAF-mutated carcinoma.
Moioli EK; Ligtenberg KG; Kenkare S; Shea CR; Soltani K
J Dermatol; 2016 Oct; 43(10):1233-1234. PubMed ID: 27094584
[No Abstract] [Full Text] [Related]
[Next] [New Search]